(Q30580854)

English

Chronic hepatitis C: interferon retreatment of relapsers. A meta-analysis of individual patient data. European Concerted Action on Viral Hepatitis (EUROHEP).

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

1 reference

based on heuristic

inferred from title

Chronic hepatitis C: interferon retreatment of relapsers. A meta-analysis of individual patient data. European Concerted Action on Viral Hepatitis (EUROHEP). (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

viral hepatitis

1 reference

based on heuristic

inferred from title

chronic hepatitis C

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Cammà C

1

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

Giunta M

2

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

Chemello L

3

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

Alberti A

4

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

Toyoda H

5

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

Trepo C

6

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

Marcellin P

7

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

Zahm F

8

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

Schalm S

9

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

Craxì A

10

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

language of work or name

0 references

publication date

1 September 1999

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

801-807

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300329

21 January 2018

Efficacy of a second cycle of interferon therapy in patients with chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300329

21 January 2018

Re-treatment of chronic hepatitis C with consensus interferon .

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300329

21 January 2018

Viral and host factors in determining response of relapsers with chronic hepatitis C to retreatment with interferon

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300329

21 January 2018

Better efficacy of a 12-month interferon alfa-2b retreatment in patients with chronic hepatitis C relapsing after a 6-month treatment: a multicenter, controlled, randomized trial. Le Groupe D'étude et De Traitement du Virus De L'hépatite C (Get.Vhc)

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300329

21 January 2018

Serum HCV RNA levels in patients with chronic hepatitis C given a second course of interferon alpha-2b treatment after relapse following initial treatment

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300329

21 January 2018

Retreatment with interferon in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300329

21 January 2018

Therapy of hepatitis C: Re-treatment with alpha interferon

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300329

21 January 2018

Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300329

21 January 2018

Therapy of hepatitis C: Overview

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300329

21 January 2018

The meaning and use of the area under a receiver operating characteristic (ROC) curve

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300329

21 January 2018

A method of comparing the areas under receiver operating characteristic curves derived from the same cases

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300329

21 January 2018

Comparison of HCV RNA levels by branched DNA probe assay and by competitive polymerase chain reaction to predict effectiveness of interferon treatment for patients with chronic hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300329

21 January 2018

Quantitative measurement of serum HCV RNA in patients with chronic hepatitis C: comparison between Amplicor HCV monitor system and branched DNA signal amplification assay.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300329

21 January 2018

Comparison of 3 quantitative HCV RNA assays--accuracy of baseline viral load to predict treatment outcome in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300329

21 January 2018

Ribavirin and interferon alfa-2b in chronic hepatitis C: assessment of possible pharmacokinetic and pharmacodynamic interactions

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300329

21 January 2018

Severe anemia following combined alpha-interferon/ribavirin therapy of chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300329

21 January 2018

Re-treatment with interferon alfa of patients with chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300329

7 January 2021

based on heuristic

inferred from DOI database lookup

Retreatment of chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300329

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose interferon-alpha 2b for re-treatment of nonresponders or relapsing patients with chronic hepatitis C. A controlled randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300329

7 January 2021

based on heuristic

inferred from DOI database lookup

Retreatment of chronic hepatitis C with interferon-alpha

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300329

7 January 2021

based on heuristic

inferred from DOI database lookup

Re-treatment of interferon-resistant patients with chronic hepatitis C with interferon-alpha

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300329

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEP.510300329

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30580854&oldid=1977747051"